Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells.

JHEP reports : innovation in hepatology·2024
Same author

Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection.

The Journal of experimental medicine·2020
Same author

A global scientific strategy to cure hepatitis B.

The lancet. Gastroenterology & hepatology·2019
Same author

Is Elimination of Hepatitis B and C a Pipe Dream or Reality?

Gastroenterology·2018
Same author

A research agenda for curing chronic hepatitis B virus infection.

Hepatology (Baltimore, Md.)·2017
Same author

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

PLoS pathogens·2017

関連する実験動画

Updated: Jun 10, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

C型肝炎ウイルスの宿主との相互作用を解析する.

Francis V Chisari1

  • 1The Scripps Research Institute, La Jolla, California 92037, USA. fchisari@scripps.edu

Nature
|August 19, 2005
PubMed
まとめ

C型肝炎ウイルス (HCV) は,世界的な大きな苦しみと死を引き起こす. 新しいインビトロ感染システムを含む最近の進歩は,この挑戦的なウイルスに対する効果的な治療法とワクチンの希望を提供します.

科学分野:

  • 肝病学とウイルス免疫学
  • 薬物の発見とワクチン開発

背景:

  • C型肝炎ウイルス (HCV) 感染は,主に肝不全と癌による,世界的な実質的な罹病率と死亡率につながります.
  • HCVの現在の治療法は,毒性,高コスト,および部分的有効性によって制限されています.
  • 信頼性の高い細胞培養や小型の動物モデルがないことは,歴史的に研究進歩を妨げています.

研究 の 目的:

  • C型肝炎ウイルスの理解と対策における最近の進歩を強調する.
  • 新しい抗ウイルス薬候補およびワクチンの開発展望の重要性を強調する.
  • 新しく開発されたin vitro HCV感染システムの影響を紹介する.

主な方法:

  • C型肝炎ウイルスに関する最新の科学文献のレビュー.
  • 新興抗ウイルス療法とワクチン研究戦略の分析.
  • 新しいインビトロ感染モデルの有用性の評価.

主要な成果:

  • いくつかの有望な新しい抗ウイルス薬候補者の特定.
  • 保護性C型肝炎ワクチンの開発の見通しが向上しました.
  • HCV感染を研究するための堅牢なインビトロシステムの確立.

さらに関連する動画

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

関連する実験動画

Last Updated: Jun 10, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

結論:

  • 最近の科学的進歩は,C型肝炎ウイルスを制御する新たな希望をもたらしています.
  • 信頼性の高いインビトロモデルの開発は,HCV研究における重要な前進です.
  • 新種の抗ウイルス薬やワクチンの継続的な研究は,HCVとの闘いに不可欠です.